These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 25923173)

  • 1. Ocular Involvement in Graft-versus-Host Disease.
    Tappeiner C; Heiligenhaus A; Dietrich-Ntoukas T
    Klin Monbl Augenheilkd; 2024 May; 241(5):619-625. PubMed ID: 38262426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Embracing the age of artificial intelligence: paradigm shifts, opportunities, and challenges in the treatment of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    An ZY; Zhang XH
    Sci China Life Sci; 2024 Jun; 67(6):1302-1304. PubMed ID: 38811443
    [No Abstract]   [Full Text] [Related]  

  • 3. Scleral Lens and Prosthetic Replacement of the Ocular Surface Ecosystem Utilization in Ocular Graft-versus-Host Disease: A Survey Study.
    Bligdon SM; Colarusso BA; Ganjei AY; Kwok A; Luo ZK; Brocks D
    Clin Ophthalmol; 2021; 15():4829-4838. PubMed ID: 34992343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic uses of scleral contact lenses for ocular surface disease: patient selection and special considerations.
    Harthan JS; Shorter E
    Clin Optom (Auckl); 2018; 10():65-74. PubMed ID: 30319297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update in Current Diagnostics and Therapeutics of Dry Eye Disease.
    Thulasi P; Djalilian AR
    Ophthalmology; 2017 Nov; 124(11S):S27-S33. PubMed ID: 29055359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term safety and efficacy of autologous platelet lysate drops for treatment of ocular GvHD.
    Pezzotta S; Del Fante C; Scudeller L; Rossi GC; Perotti C; Bianchi PE; Antoniazzi E
    Bone Marrow Transplant; 2017 Jan; 52(1):101-106. PubMed ID: 27595285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ocular graft-versus-host disease].
    Dietrich-Ntoukas T; Steven P
    Ophthalmologe; 2015 Dec; 112(12):1027-38; quiz 1039-40. PubMed ID: 26602095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratoconjunctivitis sicca manifestations in ocular graft versus host disease: pathogenesis, presentation, prevention, and treatment.
    Townley JR; Dana R; Jacobs DS
    Semin Ophthalmol; 2011; 26(4-5):251-60. PubMed ID: 21958171
    [No Abstract]   [Full Text] [Related]  

  • 9. [Management of late complications after allogeneic hematopoietic stem cell transplantation].
    Kurosawa S; Fukuda T
    Rinsho Ketsueki; 2013 Feb; 54(2):167-76. PubMed ID: 23470823
    [No Abstract]   [Full Text] [Related]  

  • 10. Bandage and scleral contact lenses for ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Stoyanova EI; Otten HM; Wisse R; Rothova A; Riemens A
    Acta Ophthalmol; 2015 Nov; 93(7):e604. PubMed ID: 25923173
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease].
    Rossi P; Delcampe A; Gueudry J; Duncombe A; Gabison E; Doan S; Muraine M
    J Fr Ophtalmol; 2015 Nov; 38(9):793-9. PubMed ID: 26456486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease.
    Takahide K; Parker PM; Wu M; Hwang WY; Carpenter PA; Moravec C; Stehr B; Martin PJ; Rosenthal P; Forman SJ; Flowers ME
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1016-21. PubMed ID: 17697963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jupiter scleral lenses in the management of chronic graft versus host disease.
    Schornack MM; Baratz KH; Patel SV; Maguire LJ
    Eye Contact Lens; 2008 Nov; 34(6):302-5. PubMed ID: 18997537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scleral lenses for severe chronic GvHD-related keratoconjunctivitis sicca: a retrospective study by the SFGM-TC.
    Magro L; Gauthier J; Richet M; Robin M; Nguyen S; Suarez F; Dalle JH; Fagot T; Huynh A; Rubio MT; Oumadely R; Vigouroux S; Milpied N; Delcampe A; Yakoub-Agha I
    Bone Marrow Transplant; 2017 Jun; 52(6):878-882. PubMed ID: 28218751
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.